The mission of the Institute for Molecular Medicine is to contribute to the understanding of and the prevention and cure of catastrophic human chronic diseases, such as autoimmune diseases, fatigue illnesses, rheumatic diseases, cancer, AIDS, and infectious and genetic diseases. This will be accomplished through innovative basic and translational research programs.
The goal of the Institute for Molecular Medicine is to apply basic and translational molecular research approaches to better understand and eventually treat catastrophic human chronic diseases.
The Institute for Molecular Medicine is building scientific programs that interface with clinical programs by recruiting outstanding scientists and physicians to work in a multidisciplinary scientific environment designed for maximum innovation and productivity.
The Plan of the Institute for Molecular Medicine is to be conducted in four phases. In Phase I, the Institute has been founded using private and institutional donations, and the initial scientists have been chosen to lead the Institute. In Phase II, a permanent physical plant will be planned, and additional scientists and administrators hired. In Phase III, a permanent building will be constructed using the endowed funds available to the Institute and the additional scientists and other necessary staff hired. In Phase IV, endowment of programs and scientists at the Institute will be completed and future scientific plans formulated.